QIAsymphony Connect: Automated nucleic acid extraction for clinical labs

Clinical sample extraction that's fast, scalable and fully automated

In today's clinical labs, the pace doesn't let up. There are more samples, more complexity and no room for error. Every step can affect the final result, so extraction needs to be consistent, traceable and dependable.

Built for these realities, the QIAsymphony Connect system is our next-generation IVD platform for automated nucleic acid extraction in mid- to high-volume clinical laboratories. It supports testing across oncology, liquid biopsy and infectious disease applications, where consistent yields, full traceability and operational flexibility are non-negotiable. Building on the trusted legacy of the QIAsymphony SP, QIAsymphony Connect represents the next step forward in clinical sample extraction.

QIAsymphony Connect on tour: Voices from the lab

Could QIAsymphony Connect fit into your lab's automation strategy? Join this short Q-rious event to take a closer look at the platform and evaluate it for your own lab. Whether you're considering an upgrade from QIAsymphony SP or comparing automated extraction systems, this session will help support your next automation decision.

Can't join us live? No problem – you can still register and catch the recording afterwards.

QIAsymphony Connect performance in liquid biopsy workflows

In an early access evaluation across six labs (n>1000 samples), where cfDNA isolation was part of routine use, users reported:

• High cfDNA yield and quality*
• Consistent, robust performance and good usability, based on qualitative user assessment

*Data available on request

Get all the specs on QIAsymphony Connect

QIAsymphony Connect can help with the day-to-day challenges of clinical nucleic acid isolation. It gives labs a more straightforward way to standardize extraction and keep things moving. Get up to speed on the technical specs of QIAsymphony Connect to see how it can support your lab.

QIAsymphony Connect is easy to use – see for yourself

Working with precious clinical samples leaves little room for error. QIAsymphony Connect helps simplify setup with a user-friendly interface and step-by-step guidance, making it easier to generate high-quality DNA and RNA with confidence.

Automation enables population-wide non-invasive prenatal testing (NIPT)

Each year, the Institute of Pathology and Genetics in Belgium processes up to 20,000 blood samples from pregnant women to detect chromosomal abnormalities. Learn how Jean-Martin Billard, MSc and his team use QIAsymphony instruments as the backbone of their cell-free DNA isolation workflow, helping make high-throughput NIPT screening possible.

Standardizing minimal residual disease (MRD) testing

Myriad Genetics develops highly sensitive MRD assays that depend on isolating concentrated, sequencing-ready cfDNA from plasma. Watch the video to see how QIAsymphony instruments help David Almanzar, PhD, and his team achieve the cfDNA quality and consistency needed to develop new assays and scale their testing.